GM-CSF has previously been demonstrated to be important in crescentic glomerulonephritis (GN).
diates podocyte injury (22) . Tubular cells are also potent producers of GM-CSF (23) , and this production can be induced in a dose-dependent manner by low molecular weight proteins (24) .
Substantial evidence exists for the participation of renal parenchymal cells in the nephritogenic immune response and subsequent inflammatory response. We have previously shown that intrinsic renal cells participate in the formation of glomerular crescents, renal leukocyte accumulation, and impairment of renal function via their production of IFN-␥, IL-12, and TNF and expression of MHC II, IL-1 receptor I (IL-1RI), and CD40 molecules (25) (26) (27) (28) (29) (30) . In view of the potential for both recruited leukocytes and renal parenchymal cells to contribute to GM-CSF production in crescentic GN, we sought to determine which cell population is responsible for the pathogenetic GM-CSF production. Our hypothesis is that in addition to the predicted important role of leukocyte GM-CSF, intrinsic renal cells contribute to the effector response in crescentic GN via GM-CSF production.
Materials and Methods

Initiation of GN and Experimental Design
Mice with a genetic deletion of GM-CSF on a C57BL/6 ϫ 129Ola background and littermate controls C57BL/6 ϫ 129Ola (WT) were bred and housed in a specific pathogen-free facility at Monash Medical Centre, Monash University (Clayton, Victoria, Australia). All animal procedures were approved by the Monash Medical Centre Animal Ethics Committee. Sheep anti-mouse GBM globulin was prepared as described previously (7) . Nonaccelerated anti-GBM was induced in 13-wk-old WT and GM-CSF Ϫ/Ϫ mice by intravenous injection of 5.15 mg of anti-GBM globulin in two divided doses 3 h apart (total dose ϭ 10.3 mg). For studies in chimeric animals, irradiation and bone marrow transplantation were performed when the mice were between 5 and 6 wk of age. GN was induced 8 wk after transplantation as described above. Renal injury in all four groups-WT (n ϭ 11), GM-CSF Ϫ/Ϫ (n ϭ 11), GM-CSF Ϫ/Ϫ 3 WT (bone marrow deficient) chimeras (n ϭ 7), and WT3 GM-CSF Ϫ/Ϫ (kidney deficient) chimeras (n ϭ 5)-was assessed 21 d after anti-GBM Ab administration. Results are expressed as the mean Ϯ SEM. The statistical significance of differences between the groups was determined by one-way ANOVA, followed by NewmanKeuls post hoc test (GraphPad Prism; GraphPad Software Inc., San Diego, CA).
Bone Marrow Transplantation
Bone marrow cell suspensions were prepared by flushing the femora and tibiae of donor mice (WT or GM-CSF Ϫ/Ϫ , 12 to 14 wk of age) with DMEM, followed by gentle resuspension of bone marrow, red blood cell lysis, and calculation of cell number (trypan blue). Recipient mice (WT or GM-CSF Ϫ/Ϫ , 5 to 6 wk of age) were conditioned with total body irradiation administered in two exposures (550 cGy) 3 h apart. Irradiated recipients received a single intravenous injection of bone marrow cells (5 ϫ 10 6 cells) within 24 h. Recipients were housed in specific pathogen-free conditions and monitored daily. Eight weeks posttransplantation, circulating leukocyte numbers, lymphocyte subsets (assessed by flow cytometry), and splenic distribution of T cells and macrophages (assessed by immunohistology) were assessed and demonstrated as normal, similar to previous reports (27, 28) .
Assessment of Systemic Immune Responses
Humoral Immune Responses to Sheep Globulin. Mouse antisheep globulin antibody titers were measured by ELISA on serum collected at the end of each experiment. Assays were performed using microtiter plates that were coated with sheep globulin at a concentration of 10 g/ml, and bound mouse Ig was detected using horseradish peroxidase-conjugated sheep anti-mouse Ig antibody (Amersham, Little Chalfont, UK), as described previously (31) .
Induction of Dermal DTH to Sheep Globulin. All mice that developed GN were challenged 24 h (day 20) before the end of the experiment by intradermal injection of 500 g of sheep globulin in 50 l of PBS into the right hind plantar surface of the footpad. The same dose of an irrelevant Ag (horse globulin) was injected into the contralateral footpad. Swelling was measured after 24 h using a micrometer (Mitutoyo, Kawasaki-Shi, Japan). DTH was assessed as the difference in swelling between the two footpads and is expressed as millimeters.
Assessment of Renal Histology and Leukocyte Infiltration
For assessing glomerular crescent formation, kidney tissue was fixed in Bouin's fixative and embedded in paraffin, and 4-m sections were stained with periodic acid-Schiff (PAS) reagent. Glomeruli were considered to exhibit crescent formation when two or more layers of cells were observed in Bowman's space. In a blinded protocol, a minimum of 50 glomeruli was assessed to determine the crescent score for each animal. The number of interstitial cells in periodic acid-Schiff-stained renal tissue sections was also assessed blindly. Five randomly selected cortical areas, which excluded glomeruli, were counted for each animal using a 10-mm 2 graticule fitted in the eyepiece of the microscope. Each high-power field represented an area of 1 mm 2 . Data are expressed as cells/mm 2 and represents the mean Ϯ SEM for four animals in each group. For determining the extent of inflammatory cell influx into glomeruli, kidney tissue and spleen were fixed in periodate/lysine/paraformaldehyde. Six-micrometer cryostat-cut sections were stained to demonstrate CD4
ϩ T cells and macrophages with mAb GK1.5 and M1/70, respectively, using a three-layer immunoperoxidase technique (16) . A minimum of 20 equatorially sectioned glomeruli were assessed blindly, and results are expressed as cells per glomerular cross section (c/gcs).
RNA was primed with 500 ng of Oligo(dT) [12] [13] [14] [15] [16] [17] [18] (Roche, Mannheim, Germany) and reverse transcribed with Super Script II (Invitrogen) according to the manufacturer's specifications to produce cDNA. Genespecific primers for mouse IFN-␥ and mouse ␤-actin were designed using Vector NTI software (Invitrogen). IFN-␥, TNF-␣, and ␤-actin cDNA was amplified using the primers (IFN-␥) F 5Ј-GAAAGACAAT-CAGGCCATCA-3Ј and R 5Ј-TTGCTGTTGCTGAAGAAGGT-3Ј, (TNF␣) F 5Ј-GCCTCTTCTCATTCCTGCTT-3Ј and R 5Ј-CACTTGGTGGTTTGC-TACGA-3Ј, and (␤-actin) F 5Ј-AGGCTGTGCTGTCCCTGTAT-3Ј and R 5Ј-AAGGAAGGCTGGAAAAGAGC-3Ј to produce PCR products of 78 bp (IFN-␥), 203 bp (TNF-␣), and 388 bp (␤-actin). Real-time PCR was performed on a Rotor Gene RG-3000 (Corbett Research, Sydney, Australia) using Faststart DNA master and Sybr Green I (Roche) according to the manufacturer's specifications. Quantification of IFN-␥, ⌻NF-␣, and ␤-actin mRNA was performed using serial dilutions of an exogenous standard. IFN-␥ and TNF-␣ levels were normalized to ␤-actin and expressed as a percentage. PCR products were confirmed by melt-curve analysis. Quantification of MHC Class II, GM-CSF, TNF, P-Selectin, CD40, and MCP-1 Expression. A single-layer immunofluorescence protocol was performed for semiquantitative assessment of GM-CSF, TNF, MHC II, and MCP-1 protein expression. Briefly, cryostat-cut, snapfrozen kidney tissue sections (6 mm) were blocked with 10% normal rat serum in 5% BSA/PBS and then incubated for 60 min at room temperature with a directly conjugated Ab at a determined concentration: FITC-conjugated rat anti-mouse GM-CSF antibody (clone MP1-22E9; BD PharMingen) used at a 1:40 dilution, PE-conjugated rat anti-mouse TNF antibody (clone MP6-XT22; BD Biosciences/PharMingen) used at a 1:20 dilution, rat anti-mouse MHC II antibody (clone Y3P; a gift from Prof. K. Shortman, Walter and Eliza Hall Institute, Melbourne, Australia) was conjugated to an Alexa Flour dye 488 (Molecular Probes, Eugene OR) used at a final dilution of 1:50, and finally PE-conjugated hamster anti-rat/mouse MCP-1 (clone 2H5; BD Biosciences/PharMingen) was used at a dilution of 1:20. All sections were assessed in a blinded protocol; a minimum of 50 glomeruli per mouse were scored semiquantitatively (0 to 3ϩ), with 0 being equivalent to background and 3ϩ equal to the most intense fluorescence observed.
Renal P-selectin was identified using a two-layer immunofluorescence method with a rabbit anti-human P-selectin (a gift from Dr. M. Berndt, Monash University) Ab, as described previously (32) . CD-40 expression was detected by immunohistochemical ABC staining with rat anti-mouse CD40 (clone 3/23; BD Bioscience/PharMingen) as the primary Ab. Acetone-fixed kidney sections (6 m) underwent citrate buffer Ag retrieval and endogenous biotin blocking (Dako, Botany Bay, Australia) before being incubated overnight at 4°C with the primary Ab at a dilution of 1:50. The secondary Ab used was rabbit anti-rat biotin (BD Biosciences), and CD40 was detected by using an avidin-biotin complex detection system (Dako). Sections were counterstained with nuclear fast red.
Functional Assessment of Glomerular Injury
Proteinuria. Mice were housed individually in cages to collect urine before administration of anti-GBM globulin and during the final 24 h (day 20) of the experiment. Urinary protein concentrations were determined by a modified Bradford method. Before induction of GN, all groups of mice had 24-h urine protein excretion in the normal range (0.5 to 2.0 mg/24 h).
Serum Creatinine. Serum creatinine concentrations were measured by an enzymatic creatininase assay.
Results
Immune Activation Is Intact in GM-CSF Ϫ/Ϫ and Chimeric Mice
Mice were sensitized by intravenous injection of sheep globulin; 20 d later, mice were challenged intradermally with sheep globulin and horse globulin (in the opposite footpad as a control Ag). Antigen-specific DTH was determined by the difference in resulting footpad swelling between Ag-and controlinjected footpads, 24 h after challenge. WT mice developed significant Ag-specific swelling (0.50 Ϯ 0.04 ⌬mm), whereas Ag-specific DTH was significantly reduced in GM-CSF Ϫ/Ϫ mice (0.13 Ϯ 0.02 ⌬mm; P Ͻ 0.05) as we have previously reported (7). In both groups of chimeric mice, dermal DTH was not significantly reduced compared with WT mice (GM-CSF 
Effects of Restricted GM-CSF Expression on Glomerular Leukocyte Recruitment and Development of Crescentic GN
WT mice developed severe proliferative crescentic GN (Figure 2) , with 33 Ϯ 2.9% of glomeruli showing crescent formation ( Figure 3A) . The development of crescents in WT mice correlated with a substantial influx of inflammatory cells into the glomerulus (T cells 0.9 Ϯ 0.08 c/gcs; macrophages 2.1 Ϯ 0.23 c/gcs) and prominent glomerular MHC II expression ( Figure  3B ). GM-CSF was abundantly expressed in interstitial and intraglomerular areas as well as on tubular cells. Expression in glomeruli was associated with both leukocytes and intrinsic renal cells ( Figure 4A) .
Absent intrinsic renal cell GM-CSF production (WT3 GM-CSF Ϫ/Ϫ chimeras) with intact leukocyte GM-CSF (demonstrated by confocal microscopy; Figure 4B ) resulted in a significant attenuation of crescent formation compared with both WT and GM-CSF 
Both Intrinsic Renal GM-CSF and Immune GM-CSF Participate in Tubulointerstitial Inflammation
Tubulointerstitial inflammation is an important sequela of proliferative and crescentic forms of GN. WT developed a marked interstitial cellular infiltrate (172 Ϯ 7 cells/mm 2 ), whereas GM-CSF Ϫ/Ϫ mice displayed limited cell recruitment into the interstitium (108 Ϯ 5 cells/mm 2 ; P Ͻ 0.001 c.f. WT). The interstitial infiltrate was also significantly attenuated in both WT3 GM-CSF Ϫ/Ϫ (134 Ϯ 5 cells/mm 2 ) and GM-CSF Ϫ/Ϫ 3 WT (128 Ϯ 4 cells/mm 2 ) chimera groups (both P Ͻ 0.001 c.f. WT). This was accompanied by reductions in both macrophages and T cells in the interstitium of chimeric animals (data not shown). Thus, both cellular sources of GM-CSF contribute to interstitial inflammation ( Figure 5) .
The tubulointerstitial changes noted in WT mice were associated with impairment of renal function indicated by elevated proteinuria and serum creatinine. A reduction of tubulointerstitial inflammation and less functional renal injury was also observed in chimeric groups and GM-CSF Ϫ/Ϫ animals ( Figure 5 ).
Renal GM-CSF Regulates VCAM-1 and MCP-1 Expression
Renal mRNA expression of adhesion molecules ICAM-1, VCAM-1, and E-selectin was analyzed by an RNAse protection assay. WT, GM Ϫ/Ϫ 3 WT, and WT3 GM-CSF Ϫ/Ϫ mice with GN all had equivalent expression of ICAM-1 and E-selectin. However, VCAM-1 mRNA was significantly downregulated in GM-CSF Ϫ/Ϫ mice and kidney-negative WT3 GM-CSF Ϫ/Ϫ chimeras (P Ͻ 0.05) compared with elevated levels observed in WT and GM-CSF Ϫ/Ϫ 3 WT chimeras. Renal P-selectin and MCP-1 were assessed semiquantitatively by immunofluorescence. P-selectin expression was not different be- tween the groups; however, MCP-1 expression was significantly elevated in the WT and GM-CSF Ϫ/Ϫ 3 WT kidneypositive chimeric mice, suggesting that intrinsic renal cell GM-CSF augments MCP-1 expression. A significant decrease in the number of glomerular cells expressing CD40 was observed in the GM-CSF Ϫ/Ϫ mice, whereas in both chimeric groups and WT mice, the number of CD40-expressing cells was similar ( Figure 6 ).
Renal GM-CSF Selectively Regulates Renal Cytokines
Expression of IL-1␤ and IL-RI mRNA was assessed by an RNAse protection assay, TNF and IFN-␥ mRNA by reverse transcription-PCR, and TNF protein expression by immunofluorescence. IL-1␤ mRNA was significantly attenuated in GM-CSF Ϫ/Ϫ and WT3 GM-CSF 
Discussion
Dysregulated expression of GM-CSF is associated with a range of pathologic conditions, including leukemias, and chronic inflammatory conditions such, as rheumatoid arthritis, EAE, and glomerulonephritis. As both leukocyte and many resident tissue cells produce GM-CSF, studies have attempted to determine the important cellular source of GM-CSF. A recent study has shown that EAE development was dependent on the local delivery of GM-CSF by retrovirally transduced Ag-specific T cells. Thus, overexpression of GM-CSF in the central nervous system drives the effector phase of EAE (33) .
As both renal parenchymal cells and infiltrating immune cells are capable of producing GM-CSF, it is important to determine whether GM-CSF produced by either or both cellular sources contribute to the exacerbation of GN. To address this issue, we studied the development of crescentic GN in chimeric mice: WT3 GM-CSF Ϫ/Ϫ chimeric mice, which had restricted expression of GM-CSF to bone marrow-derived cells, and GM-CSF Ϫ/Ϫ 3 WT chimeras, which had absent leukocyte GM-CSF but intact intrinsic renal cell ability to produce GM-CSF. The effects of restricted GM-CSF expression on the development of crescentic GN indicated a major role for renal cellderived GM-CSF in the formation of cellular crescents, glomerular MHC II expression, increased serum creatinine, MCP-1 production, and VCAM mRNA and IL-1␤ mRNA expression. These parameters were similar in GM-CSF Ϫ/Ϫ 3 WT kidneypositive chimeras and WT mice but significantly reduced in mice with total absence of GM-CSF and WT3 GM-CSF Ϫ/Ϫ kidney-negative chimeric mice. In comparison, chimeras with GM-CSF-deficient bone marrow allowed the role of leukocytederived GM-CSF to be determined as relatively minor in the above-mentioned parameters. In the two chimeric groups, glomerular T cell recruitment, the number of CD40-positive cells in glomeruli, and renal IFN-␥ mRNA and TNF protein expression were similar to elevated values measured in WT mice, indicating redundancy in the production of GM-CSF with either source being sufficient to drive these aspects of the inflammatory response. Glomerular macrophages, proteinuria, and interstitial infiltrate were similar in both chimeras. These parameters of inflammation were significantly reduced from WT mice but also significantly increased compared with GM-CSF Ϫ/Ϫ mice, indicating that neither source of GM-CSF is capable of completely compensating for the other's deficiency. Both sources are required for the full development of these aspects of glomerular injury in crescentic GN. Finally, IL-1RI, ICAM-1, P-selectin, and E-selectin expression was unaffected by the absence of either source of GM-CSF or its total absence, indicating that GM-CSF has no role in the regulation of these proinflammatory molecules.
As macrophage numbers were significantly reduced in both chimeric groups, we speculate that recruitment of monocytes into the inflamed kidney is particularly sensitive to GM-CSF levels. Several studies have demonstrated that GM-CSF promotes the infiltration of monocytes and macrophages after tissue injury (34, 35) . Furthermore, GM-CSF mRNA and protein synthesis occurs in both monocytes and endothelial cells as a result of direct cell-to-cell interaction (36) . Therefore, GM-CSF produced locally (by both renal cells and bone marrow-derived cells) via monocyte-renal cell interactions may modulate adhesive interactions between intrinsic renal cells and monocytes and consequently the recruitment of macrophages into the glomerular lesion.
Despite glomerular macrophage numbers' being significantly decreased in leukocyte-deficient GM-CSF chimeras, MHC II expression was unaffected. As MHC II is regarded as an activation marker for macrophages (37-39)/mesangial cells (40) , this finding indicates that renal GM-CSF plays a dominant role in local activation of macrophages and/or mesangial cells. We demonstrated previously the dependence of cell-mediated immune renal injury in anti-GBM GN on intrinsic renal cell expression of MHC II (30) . GM-CSF induces MHC II expression on the surface of bone marrow-derived monocytes (41), elevates MHC II expression on macrophages, and skews the cytokine response of T cells toward Th1 (42) . Hence, renal cellderived GM-CSF may be vital to sustain an elevated expression of MHC II on macrophages and thus helping to sustain the local Th1 biased response and exacerbate GN.
The correlation between glomerulopathies associated with proteinuria and progressive tubulointerstitial injury has been documented extensively in a clinical setting. One obvious explanation for this relationship is that the magnitude of proteinuria is a reflection of the severity of the underlying glomerular disease (43) . Although some evidence suggests that proteinuria may contribute directly to renal injury (specifically tubular and interstitial changes), it remains unclear whether proteinuria is a cause or a consequence of progressive renal injury (24) . In this study, GM-CSF Ϫ/Ϫ 3 WT chimeric mice developed severe glomerular crescent formation accompanied by glomerular MHC II expression but significantly attenuated proteinuria and tubulointerstitial inflammation. Our studies suggest that events in- dependent from the glomerular capillary circulation can contribute to pathogenic proteinuria. Support for the pathogenic role of interstitial mononuclear inflammatory cell infiltration has come from studies in which reduced infiltrates have been associated with attenuated renal injury and preserved renal function (44 -47) .
As the direct adhesive interaction of monocytes and endothelial cells is one proposed stage affected in both chimeric mice, we explored the expression of adhesion molecules involved in leukocyte emigration from vessels during inflammation: ICAM-1, VCAM-1, P-selectin, and E-selectin. We found renal ICAM-1, P-selectin, and E-selectin expression to be equivalent in WT, GM-CSF Ϫ/Ϫ 3 WT,and WT3 GM-CSF Ϫ/Ϫ mice with GN. However, VCAM-1 expression was significantly downregulated in WT3 GM-CSF Ϫ/Ϫ chimeras (P Ͻ 0.05) compared with elevated levels observed in WT and GM-CSF Ϫ/Ϫ 3 WT chimeras. Substantial expression of renal VCAM-1 has been demonstrated in proliferative and crescentic forms of nephritis both clinically and experimentally (48 -50) . In the first 7 d of a nephrotoxic nephritis model, administration of anti-VCAM-1 mAb had little effect on disease progression (49) . However, a role for VCAM-1 in the later development of renal injury has been demonstrated. In a mercuric chloride model of nephritis, administration of anti-VCAM-1 mAb inhibited leukocyte recruitment into the renal interstitium (51), whereas tubular expression of VCAM-1 seems to be associated with the degree of histologic damage (52) . Thus, GM-CSF produced by tubular cells may upregulate tubulointerstitial VCAM-1 expression, which influences interstitial inflammation and renal function.
The pathway of activation and interaction between intrinsic renal cells and infiltrating immune cells invariably involves proinflammatory cytokines. We previously demonstrated differing contributions of IFN-␥, IL-12, TNF, IL-1, and IL-1RI to this complex local inflammatory response. As GM-CSF has the capacity to be involved in the upregulation of TNF, IL-1␤, MCP-1, and IL-6 (6), we explored possible mechanisms by which renal-and leukocyte-derived GM-CSF may amplify injury. Our studies demonstrate that GM-CSF does not influence the expression of IL-1RI in the kidney and that either cellular source of GM-CSF is capable of augmenting IFN-␥ mRNA or TNF protein expression. Finally, we demonstrated that GM-CSF may influence the inflammatory phase of crescentic GN and tubular injury via IL-1␤ and MCP-1. A significant reduction of IL-1␤ mRNA and MCP-1 expression in WT3 GM-CSF Ϫ/Ϫ kidney-negative chimeras (P Ͻ 0.05) was observed, whereas both were significantly increased in WT and GM-CSF Ϫ/Ϫ 3 WT kidney-positive chimeras. Therefore, we propose that GM-CSF released by renal parenchymal cells increases the numbers of activated macrophages that are capable of releasing further inflammatory mediators (e.g., IL-1␤), previously demonstrated to be critical in the progression of GN (29) . Mesangial cells produce MCP-1 in response to IL-1␤ (53); furthermore, blocking MCP-1 via Ab reduces glomerular injury and proteinuria (54, 55) . Hence, renal GM-CSF may regulate glomerular and tubular injury through MCP-1 by influencing IL-1␤ or in an autocrine feedback loop as renal cells have been demonstrated to be the principal producers of MCP-1 (56). mice. Renal VCAM-1, ICAM-1, and E-selectin expression relative to the housekeeping gene L32 assessed by RNAse protection assay and results are expressed in arbitrary units (AU). P-selectin and MCP-1 expression was assessed semiquantitatively by immunofluorescence, scored 0 to 3ϩ. Glomerular CD40-positive cells were detected by immunohistochemical ABC staining. WT, GM-CSF Ϫ/Ϫ 3 WT chimeras, WT3 GM-CSF Ϫ/Ϫ , and GM-CSF Ϫ/Ϫ mice had equivalent expression of ICAM-1, P-selectin, and E-selectin. A significant amplification of VCAM-1 mRNA and MCP-1 protein expression was noted in WT mice and GM-CSF Ϫ/Ϫ 3 WT chimeras compared with WT3 GM-CSF Ϫ/Ϫ chimeras and GM-CSF Ϫ/Ϫ mice. The number of CD40-positive cells in the glomeruli of GM-CSF Ϫ/Ϫ mice was significantly less than in chimeric and WT mice. ૺP Ͻ 0.05 c.f. WT mice; fP Ͻ 0.05 c.f. GM-CSF Ϫ/Ϫ 3 WT kidney-negative chimeric mice.
